Stay updated on Trametinib and Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trametinib and Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trametinib and Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Major changes include a user-visible status notice about government funding and NIH Clinical Center operations, and a version update from v3.1.0 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-06T06:58:49.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:39:09.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Updated revision to v3.0.2 and removed the Back to Top link.
    Difference
    0.1%
    Check dated 2025-09-14T21:43:27.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.1%
    Check dated 2025-09-07T18:07:42.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of specific genetic terms and pharmacological agents, while removing various related topics and location details.
    Difference
    2%
    Check dated 2025-08-31T12:22:23.000Z thumbnail image
  9. Check
    74 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T04:40:14.000Z thumbnail image

Stay in the know with updates to Trametinib and Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trametinib and Pembrolizumab in NSCLC Clinical Trial page.